12,757 items were found to be eligible for incentives of 30% of the difference in drug prices if pharmacies dispense generic substitution, which is cheaper than prescription drugs. It decreased 48 items compared to the previous month. The HIRA recently guided the 'Billing Method of Drugs Subjected to Incentives for low-price generic substitution in August'. As of August, 25,745 items were listed on the drug benefits, with 49.5% of the drugs available for generic substitution.

Among Metformine and Ranitidines, 203 items of drug sales and suspension are excluded from incentive payments. The generic substitution to low-cost drugs is a system that allows pharmacies to get back 30% of the difference in drug